10 trials changed in the last 30 days: 0 stopped, 4 with notable changes, 6 with minor changes only.
Primary completion pushed from May 1, 2028 to Jan 1, 2029
Also in this update: Primary endpoint(s) modified; Study completion pushed from May 15, 2028 to May 15, 2029
Maastricht University Medical CenterNot applicable NCT07287358 Registry history of NCT07287358 on ClinicalTrials.gov (opens the registry)
Updated
Recruitment opened
Also in this update: Primary and study completion pushed from Oct 15, 2027 to Dec 15, 2027
Maastricht University Medical CenterNot specified NCT07647640 Registry history of NCT07647640 on ClinicalTrials.gov (opens the registry)
Updated
Recruitment opened
Maastricht University Medical CenterNot applicable NCT07805057 Registry history of NCT07805057 on ClinicalTrials.gov (opens the registry)
Updated
Study completion date changed from estimate of Apr 1, 2025 to May 22, 2026
Also in this update: Trial completed; Final enrollment: 14 participants (planned 40)
Maastricht University Medical CenterNot specified NCT04569006 Registry history of NCT04569006 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
Also in this update: Primary completion date changed from estimate of May 1, 2026 to Dec 18, 2025
Maastricht University Medical CenterNot specified NCT06624618 Registry history of NCT06624618 on ClinicalTrials.gov (opens the registry)
Updated
Enrollment closed, study ongoing
Also in this update: Primary completion pushed from Jul 2026 to Dec 2026; Study completion pushed from Jul 2026 to Dec 2027
Maastricht University Medical CenterNot applicable NCT03807310 Registry history of NCT03807310 on ClinicalTrials.gov (opens the registry)
Updated
Primary and study completion pushed from Dec 2027 to Feb 2028
Maastricht University Medical CenterNot applicable NCT06832761 Registry history of NCT06832761 on ClinicalTrials.gov (opens the registry)
Updated
Primary completion pushed from Dec 31, 2026 to Apr 30, 2027
Also in this update: Study completion pushed from Apr 30, 2027 to Jul 31, 2027
Maastricht University Medical CenterNot applicable NCT05640089 Registry history of NCT05640089 on ClinicalTrials.gov (opens the registry)
Updated
Interventions modified
Maastricht University Medical CenterNot applicable NCT04918745 Registry history of NCT04918745 on ClinicalTrials.gov (opens the registry)
Updated
Registry marked status Unknown (sponsor has not verified the record since Sep 2022); last known: Recruiting
Maastricht University Medical CenterPhase 4 NCT03917303 Registry history of NCT03917303 on ClinicalTrials.gov (opens the registry)
Changed
| Phase 1/2 | 1 | |
| Phase 2 | 4 | |
| Phase 3 | 1 | |
| Phase 4 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT05716945 | The OPTIMISE Study | Pseudophakic Bullous Keratopathy | Recruiting | 2025-10-06 |
| NCT06499415 | Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the… | Actinic Keratoses | Recruiting | 2025-05-11 |
| Phase 3 | ||||
| NCT05367089 | The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent… | Candidiasis, Vulvovaginal | Recruiting | 2023-05-17 |
| Phase 2 | ||||
| NCT07402343 | Tarlatamab for SCLC Brain Metastases | Small Cell Lung Cancer | Recruiting | 2026-07-31 |
| NCT07485452 | Boosting Osimertinib Blood Brain Barrier Penetration | Non-Small Cell Lung Cancer | Recruiting | 2026-06-05 |
| NCT06335069 | 18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer. | Breast Cancer | Recruiting | 2025-09-24 |
| NCT06401824 | Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases | NSCLC Stage IV | Recruiting | 2025-05-06 |
| Phase 1/2 | ||||
| NCT04954599 | Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI | Unspecified Adult Solid Tumor, Protocol Specific | Recruiting | 2025-10-07 |
| Not applicable | ||||
| NCT06832761 | Lifestyle Intervention in the Memory Clinics of General and Academic Hospitals Trial | Lifestyle Intervention | Recruiting | 2026-10-15 |
| NCT05640089 | FMRI-neurofeedback in Depression | Depression, Unipolar | Recruiting | 2026-10-13 |
| NCT07805057 | Magnetic Brain Stimulation in Small Fiber Neuropathy | Small Fiber Neuropathy | Recruiting | 2026-09-21 |
| NCT07641985 | Autologous Fat Grafting for Total Breast Reconstruction in Irradiated Breast Cancer… | Breast Cancer | Recruiting | 2026-08-21 |
| NCT07715955 | Effect of Probiotics on Appetite Regulation in Adults With Overweight/Obesity | Healthy | Recruiting | 2026-08-12 |
| NCT07422220 | Long-Term Effects of Walnut Consumption on Brain Function | Healthy | Recruiting | 2026-07-24 |
| NCT03983603 | Plant Stanol Esters and Preventing Asthma Symptoms | Asthma, Allergic | Recruiting | 2026-06-25 |
| NCT07556887 | Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation | Carotid Artery Stenosis Symptomatic | Recruiting | 2026-05-15 |
| NCT07547176 | Amino Acid Oxidation of Whole-Food Protein: a Dose-Response Crossover Trial in Young… | Protein Metabolism | Recruiting | 2026-04-23 |
| NCT07395973 | The Effects of a 4-week Supplementation With a Ketogenic Nutrient Mix on 24-hour… | Overweight and Obesity | Recruiting | 2026-02-09 |
| NCT06923644 | Targeted Precision Nutrition Strategy To Prevent Chronic Metabolic Diseases | Obesity and Overweight | Recruiting | 2026-01-20 |
| NCT06082349 | The N-LVA Study: RCT Comparing LVA vs. Sham Surgery in Cancer-related Lymphedema | Lymphedema, Secondary | Recruiting | 2026-01-16 |
| NCT06406803 | The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle… | Cancer of Prostate | Recruiting | 2026-01-16 |
| NCT06700187 | Frequency of Interrupting Sitting and Cognitive Function | Sedentary Behaviors | Recruiting | 2026-01-14 |
| NCT06714240 | Enhanced Protein Intake to Support Muscle Protein Synthesis in ICU | Critical Illness | Recruiting | 2025-12-10 |
| NCT07256340 | Measuring Total Energy Expenditure in Critically Ill Patients Using the Doubly Labelled… | Critical Illness | Recruiting | 2025-12-10 |
| NCT06746805 | The Effect of Acute Ketone Monoester Supplementation on Glucose Oxidation During Exercise | Exercise Metabolism | Recruiting | 2025-09-24 |
Breast Cancer (8) · Heart Disease (8) · Obesity (6) · Diabetes (3) · Head & Neck Cancer (3) · Lung Cancer (3) · Atrial Fibrillation (2) · Coronary Artery Disease (2) · Crohn's Disease (2) · Heart Failure (2)